A phase Ib dose-escalation study of TRC105 in combination with bevacizumab for advanced solid tumors

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2012
This article has no abstract
Epistemonikos ID: 8a4044db0cf127b049e9296794da61bed4274982
First added on: Feb 05, 2025